Literature DB >> 16707531

Asporin repeat polymorphism in rheumatoid arthritis.

B Torres1, G Orozco, J R García-Lozano, J Oliver, O Fernández, M A González-Gay, A Balsa, A García, D Pascual-Salcedo, M A López-Nevot, A Núñez-Roldán, J Martín, M F González-Escribano.   

Abstract

BACKGROUND: Asporin belongs to a family of proteins associated with the cartilage matrix.
OBJECTIVE: To investigate the role of the functional polymorphism consisting of an aspartic acid (D) repeat polymorphism located in the ASPN gene in the susceptibility to and clinical outcome of rheumatoid arthritis.
METHODS: A total of 803 Spanish Caucasian patients with rheumatoid arthritis and 904 controls of the same ethnic origin and matched for age and sex were included in the study. The asporin D repeat polymorphism was genotyped using polymerase chain reaction with a fluorescent primer.
RESULTS: No significant differences were detected in the distribution of the 10 alleles found in our population on comparing patients with rheumatoid arthritis with control groups. Nevertheless, individuals bearing D14 produced rheumatoid factor more often than the rest (85.7% v 72.1%, p = 0.006, odds ratio (OR) = 2.35, 95% confidence interval 1.21 to 4.50), and the mean (SD) onset age was higher in the group of individuals bearing D13 (50.09 (13.94)) compared with the rest (47.21 (14.31)), although the difference did not reach significance (p = 0.06).
CONCLUSION: The results do not support a major role for asporin D repeat polymorphism in the susceptibility to rheumatoid arthritis. Nevertheless, they support the influence of this gene on the outcome of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16707531      PMCID: PMC1798423          DOI: 10.1136/ard.2006.055426

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  9 in total

1.  Expression pattern and gene characterization of asporin. a newly discovered member of the leucine-rich repeat protein family.

Authors:  S P Henry; M Takanosu; T C Boyd; P M Mayne; H Eberspaecher; W Zhou; B de Crombrugghe; M Hook; R Mayne
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

2.  Identification and characterization of asporin. a novel member of the leucine-rich repeat protein family closely related to decorin and biglycan.

Authors:  P Lorenzo; A Aspberg; P Onnerfjord; M T Bayliss; P J Neame; D Heinegard
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

3.  Matrix metalloproteinase 28/epilysin expression in cartilage from patients with rheumatoid arthritis and osteoarthritis: comment on the article by Kevorkian et al.

Authors:  Shigeki Momohara; Hiroshi Okamoto; Kouichirou Komiya; Katsunori Ikari; Masahiro Takeuchi; Taisuke Tomatsu; Naoyuki Kamatani
Journal:  Arthritis Rheum       Date:  2004-12

4.  Investigating the aspartic acid (D) repeat of asporin as a risk factor for osteoarthritis in a UK Caucasian population.

Authors:  Zehra Mustafa; Barbara Dowling; Kay Chapman; Janet S Sinsheimer; Andrew Carr; John Loughlin
Journal:  Arthritis Rheum       Date:  2005-11

Review 5.  Matrix metalloproteinases: role in arthritis.

Authors:  Peter S Burrage; Kimberlee S Mix; Constance E Brinckerhoff
Journal:  Front Biosci       Date:  2006-01-01

6.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

7.  An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis.

Authors:  Hideki Kizawa; Ikuyo Kou; Aritoshi Iida; Akihiro Sudo; Yoshinari Miyamoto; Akira Fukuda; Akihiko Mabuchi; Akihiro Kotani; Akira Kawakami; Seizo Yamamoto; Atsumasa Uchida; Kozo Nakamura; Kohei Notoya; Yusuke Nakamura; Shiro Ikegawa
Journal:  Nat Genet       Date:  2005-01-09       Impact factor: 38.330

Review 8.  Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases.

Authors:  Jennifer M Milner; Tim E Cawston
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2005-06

9.  Expression profiling of metalloproteinases and their inhibitors in cartilage.

Authors:  Lara Kevorkian; David A Young; Clare Darrah; Simon T Donell; Lee Shepstone; Sarah Porter; Sarah M V Brockbank; Dylan R Edwards; Andrew E Parker; Ian M Clark
Journal:  Arthritis Rheum       Date:  2004-01
  9 in total
  5 in total

Review 1.  Emerging proteoglycans and proteoglycan-targeted therapies in rheumatoid arthritis.

Authors:  Brianna Hurysz; Nunzio Bottini
Journal:  Am J Physiol Cell Physiol       Date:  2022-04-27       Impact factor: 5.282

2.  Absence of association of asporin polymorphisms and osteoarthritis susceptibility in US Caucasians.

Authors:  U Atif; A Philip; J Aponte; E M Woldu; S Brady; V B Kraus; J M Jordan; M Doherty; A G Wilson; R W Moskowitz; M Hochberg; R Loeser; J B Renner; M Chiano
Journal:  Osteoarthritis Cartilage       Date:  2008-04-22       Impact factor: 6.576

3.  Association of the aspartic acid-repeat polymorphism in the asporin gene with age at onset of knee osteoarthritis in Han Chinese population.

Authors:  Dongquan Shi; Takahiro Nakamura; Jin Dai; Long Yi; Jianghui Qin; Dongyang Chen; Zhihong Xu; Yong Wang; Shiro Ikegawa; Qing Jiang
Journal:  J Hum Genet       Date:  2007-06-30       Impact factor: 3.172

4.  Association of the D repeat polymorphism in the ASPN gene with developmental dysplasia of the hip: a case-control study in Han Chinese.

Authors:  Dongquan Shi; Jin Dai; Pengsheng Zhu; Jianghui Qin; Lunqing Zhu; Hongtao Zhu; Baocheng Zhao; Xusheng Qiu; Zhihong Xu; Dongyang Chen; Long Yi; Shiro Ikegawa; Qing Jiang
Journal:  Arthritis Res Ther       Date:  2011-02-17       Impact factor: 5.156

5.  Comparative analysis of gene expression profiles in normal hip human cartilage and cartilage from patients with necrosis of the femoral head.

Authors:  Ruiyu Liu; Qi Liu; Kunzheng Wang; Xiaoqian Dang; Feng Zhang
Journal:  Arthritis Res Ther       Date:  2016-05-04       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.